1 year ...My Hair restoration Journey Progress Pictures 12/24/2025
The conversation is about a user's hair restoration journey using topical finasteride/minoxidil, switching to dutasteride due to shedding, and experiencing regrowth. The user reports no side effects from dutasteride and applies it topically twice daily.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity 3 months on topical min + fin + Redensyl and hair is worse. Nonstop shedding & dry flaky scalp
A 25-year-old male is experiencing worsening hair loss after 3 months of using topical minoxidil, finasteride, and Redensyl, with users suggesting patience, potential hormonal factors, and considering alternative treatments like dutasteride and oral minoxidil. Shedding is noted as a common phase, indicating potential future hair regrowth.
community 18mo progress - topical fin/min + oral min/dut
The user experienced significant hair regrowth using topical finasteride/minoxidil and oral minoxidil/dutasteride, with some mild side effects that diminished over time. They plan to add microneedling to their regimen and have seen hair shedding cycles every six months, followed by thicker regrowth.
community i got more results 1 month 5 mg oral minoxidil and 1 mg dutasteride then i did 6 months on finasteride and topical minoxidil
A user reported better hair regrowth with 5 mg oral minoxidil and 1 mg dutasteride than with finasteride and topical minoxidil, calling topical minoxidil a scam. Replies varied, with some defending topical minoxidil, questioning the user's application method, and suggesting that previous treatments might be contributing to the observed results.
community 7 months on finasteride + topical minoxidil + tretinoin, including 4 months on dutasteride.
The user experienced significant hair regrowth, especially at the hairline, after 7 months using finasteride, topical minoxidil, tretinoin, and later dutasteride, but noted changes in hair texture. They are considering adding KX826 and have not experienced side effects.
community 6 months and a half on topical min and fin
A user experienced significant hair regrowth after 6.5 months using topical minoxidil, finasteride, microneedling, and keto shampoo, despite initial shedding. They plan to switch to oral dutasteride for further improvement.
community M23: Oral min and fin 6months + no regrowth or progress
The user has been using oral minoxidil and finasteride for 6 months with no regrowth and increased shedding, and recently switched to a higher dose of minoxidil. Suggestions include switching to dutasteride, adding topical anti-androgens like RU58841, and considering a hair transplant.
Related Research
6 / 6 resultsresearch The Use of Oral Dutasteride, Minoxidil, and Finasteride for Treating Endocrine Therapy-Induced Hair Loss from Breast Cancer Treatment: A Case Series Study
Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.
research B‐ RAF , naevi and melanoma: a complex relationship
Male hair loss is mainly due to thinner hair, not less hair.
research Hair diameter vs. hair density in male androgenetic alopecia
Hair loss is due to thinner hairs, not less hairs; hair diameter indicates balding progression and treatment effectiveness.
research Finasteride in the treatment of female pattern (androgenic) alopecia: a case report and review of the literature.
In this report, a 44-year-old woman with female pattern alopecia experienced significant hair regrowth after 3.5 months of oral finasteride, with no side effects, after not responding to topical minoxidil.
research Female pattern alopecia: current perspectives
This review discusses the current therapeutic options for female pattern hair loss and emphasizes the need for managing patient expectations of permanent regrowth, reporting no new clinical results.
research Androgens and hair loss
This review discusses the pathogenesis and treatment of androgenetic alopecia, highlighting genome associations and newer topical formulations, but reports no new clinical results.